InvestorsHub Logo
Followers 37
Posts 2036
Boards Moderated 0
Alias Born 09/29/2007

Re: Zilla post# 52

Thursday, 10/22/2009 1:24:20 AM

Thursday, October 22, 2009 1:24:20 AM

Post# of 1605
Bot some today but b/a shifted up rather quickly. I may have to use your approach to accumulate shares over extended period.

I've looked over 10q and could not find royalty agreement with Elan over Bapineuzumab. Even a mid-single digit percentage would be substantial for Intellect. You know better than I do having invested in TTNP at going out of business prices. Alzheimer's market is a big market and will get much bigger going forward.

Company is cash strapped and that may hamper future development and progress, but the threat of bankruptcy is nil as far as I am concerned. However, failure of Bapieuzumab and shaky financial may cause the stock to take a big hit, but no bk. Company's understanding of Alzheimer's disease, patent portfolio and drug candidates will provide strong support for the stock price.

I took lots profits off the table on AVAX. Just ran up too much too fast in less than 2 month period. Had 730k free AVAX shares. :)

Waiting for a pullback to reenter here.